supplemental Biologics License Application

• Healthcare
• Marketing
• News
• Pharma & Biotech
• Switzerland

Roche on Tecentriq’s US FDA Priority Review grant: New treatment options are urgently needed in early-stage non-small cell lung cancer

Application is being reviewed under the US FDA’s Real-Time Oncology Review pilot programme Based on results of the Phase III IMpower010…